UBS Lux Equity Fund Biotech USD vs Protean Select

UBS Lux Equity Fund Biotech USD vs Protean Select

1. UBS Lux Equity Fund Biotech USD

  • Security

    UBS Lux Equity Fund Biotech USD P-acc

  • Fee

    2.25%

  • ISIN

    LU0069152568

  • Holdings

    9

2. Protean Select

  • Security

    Protean Select

  • Fee

    2.60%

  • ISIN

    SE0017830748

  • Holdings

    23

Fund Holdings

We have information about 11 holdings in UBS Lux Equity Fund Biotech USD, where the largest holding is Regeneron Pharmaceuticals (10.04), followed by Moderna (9.21) and Vertex (8.44). In comparison with Protean Select, we have 25 holdings where RaySearch is the largest holding (4.07), followed by Hexagon (4.04) and Getinge (3.64).

All Holdings

Here we compare the holdings in UBS Lux Equity Fund Biotech USD and Protean Select.

UBS Lux Equity Fund Biotech USD Protean Select
1. Regeneron Pharmaceuticals Inc
10.04 %
1. RaySearch Laboratories B
Sweden
4.07 %
2. Moderna Inc
9.21 %
2. Hexagon B
Sweden
4.04 %
3. Vertex Pharmaceuticals Inc
8.44 %
3. Getinge B
Sweden
3.64 %
4. Alnylam Pharmaceuticals Inc
8.08 %
4. Nordea Bank Abp
Finland
3.43 %
5. AbbVie Inc
USA
4.91 %
5. Devyser Diagnostics AB
Sweden
3.18 %
6. Gilead Sciences Inc
USA
4.66 %
6. Acast AB
Sweden
3.11 %
7. Amgen Inc
USA
4.43 %
7. Huhtamäki Oyj
Finland
3.1 %
8. BioNTech SE
4.13 %
8. Sampo Oyj A
Finland
3.04 %
9. Karuna Therapeutics Inc
3.75 %
9. Mowi
Norway
3.01 %
- 10. Essity B
Sweden
2.98 %
- 11. KONE Oyj
Finland
2.91 %
- 12. Skanska B
Sweden
2.84 %
- 13. Kojamo Oyj
Finland
2.78 %
- 14. Elekta B
Sweden
2.62 %
- 15. Lindex Group
Finland
2.56 %
- 16. Atlas Copco B
Sweden
2.41 %
- 17. MEKO Sweden AB
Sweden
2.29 %
- 18. Ambea
2.24 %
- 19. Coor Service Management Holding
2.21 %
- 20. Lagercrantz Group B
Sweden
2.19 %
- 21. Novo Nordisk B
Denmark
2.08 %
- 22. Indutrade AB
Sweden
2.07 %
- 23. Tryg A/S
Denmark
2.05 %

The list of fund holdings was last updated on July 25, 2025.